Immunotherapy of osteosarcoma based on immune microenvironment modulation
Osteosarcoma is a highly malignant tumor with unsatisfactory therapeutic outcomes achieved by chemotherapy, radiotherapy, and surgery. As an emerging oncological treatment, immunotherapy has shown potential in the clinical management of many tumors but has a poor response rate in osteosarcoma. The i...
Saved in:
Main Authors: | Heping Lian, Jiakui Zhang, Shuna Hou, Shuang Ma, Jiachen Yu, Wei Zhao, Duoyi Zhao, Zhiyu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1498060/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
by: Lin Zhang, et al.
Published: (2025-01-01) -
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01) -
A telomere-related signature for predicting prognosis and assessing immune microenvironment in osteosarcoma
by: Shihao Li, et al.
Published: (2025-01-01) -
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
by: Shaoyan Shi, et al.
Published: (2025-01-01) -
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)